Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 28Ovarian Neoplasms 27Breast Neoplasms 27Lung Neoplasms 26Carcinoma, Ovarian Epithelial 20Fallopian Tube Neoplasms 15Adenocarcinoma of Lung 14Head and Neck Neoplasms 13Brenner Tumor 11Uterine Cervical Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Urinary Bladder Neoplasms 9Esophageal Neoplasms 9Stomach Neoplasms 8Endometrial Neoplasms 8Urethral Neoplasms 7Adenocarcinoma, Bronchiolo-Alveolar 6Sarcoma 5Prostatic Neoplasms 5Adenocarcinoma Of Esophagus 5Neurotoxicity Syndromes 4Neoplasm Metastasis 4Testicular Neoplasms 3Salivary Gland Neoplasms 3Radiation Injuries 3Esophageal Squamous Cell Carcinoma 3Breast Neoplasms, Male 3Thymoma 2Testicular Germ Cell Tumor 2Small Cell Lung Carcinoma 2

Interventions

Taxes 1Paclitaxel 1Ifosfamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinosarcoma × Paclitaxel × Clear all
NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

GOG Foundation

Phase 3 Unknown
637 enrolled 18 charts
GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡